This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mi He - Innovator in Antibody Development
Introduction
Mi He is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on enhancing the efficacy of therapeutic agents used in treating various diseases.
Latest Patents
Mi He holds a patent for "Anti-Human CD19 Antibodies with High Affinity." This innovative patent represents a breakthrough in the treatment of conditions such as leukemia and lymphoma, where targeting CD19 can lead to improved patient outcomes. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Mi He is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves research and development, where he applies his expertise to create effective therapeutic solutions. His work at Hoffmann-La Roche has positioned him as a key player in the biotechnology sector.
Collaborations
Mi He collaborates with Claudia Ferrara Koller, a talented woman in the field. Together, they work on innovative projects that aim to push the boundaries of current medical treatments. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Mi He is a distinguished inventor whose work in antibody development is making a significant impact in the medical field. His contributions, particularly through his patent, highlight the importance of innovation in healthcare.